Call Anytime -
Before the Stryker hip recall was voluntarily issued by the manufacturer in July 2012, an estimated 20,000 Stryker Rejuvenate modular-neck hip stems were sold throughout the United States.
That means thousands of patients who went in for routine hip replacement surgeries received devices whose metal components had the potential to fret or corrode, allowing for toxic metal debris to shed into their surrounding tissues and bloodstream.
As a result of receiving these implants, many have suffered from metal ion poisoning, also known as metallosis, hip replacement failure, and other frightening side effects, which have forced them to undergo (sometimes multiple!) corrective surgeries to remove the hip replacements.
Since the Stryker hip recall of July 2012, the nationwide litigation of Stryker Rejuvenate hip lawsuits has continued to grow in federal and state courts throughout the U.S.
On Feb. 28, 2013, NorthJersey.com reported that over 80 Stryker hip lawsuits had been filed in New Jersey Superior Court. The pretrial proceedings for these claims are to be overseen by Judge Brian R. Martinotti and heard in New Jersey Superior Court in Hackensack. This arrangement was ordered by New Jersey Supreme Court in January.
According to the article, the growing number of lawsuits filed against Stryker may cause the case to become “one of the biggest mass-tort litigations in the country.”
One lawyer quoted by the publication said she has already filed 30 claims on behalf of her clients who allegedly suffered injuries from the devices, and is working with another 150 patients in filing similar suits.
In federal court, one Stryker hip lawsuit plaintiff recently requested to consolidate all claims in the U.S. District Court, District of Minnesota.
According to the motion he filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) in February, creating a multidistrict litigation (MDL) in the Minnesota federal court would work well since 10 out of 30 claims were filed at that location. The convenience of all parties would be served, and duplicate discoveries found in multiple trials could be avoided.
Since the beginning of 2012, the U.S. Food and Drug Administration (“FDA”) has received more than 60 adverse event reports of metal corrosion, tissue inflammation and other complications stemming from the Stryker hip implants. The high number of these reports helped fuel concerns that ultimately led to the Stryker Rejuvenate hip recall.
If you have a Stryker Rejuvenate or ABG II hip implant and these side effects sound familiar, keep reading.
Did you recently receive a letter from your doctor with information about the Broadspire Stryker claims program? Broadspire Services, Inc. is a third-party claims administrator that Stryker has hired to process claims for patient expenses related to the Stryker Rejuvenate recall. According to information on Stryker’s website, Stryker will be reimbursing individuals impacted by the Rejuvenate and ABG II modular hip stem recall for necessary revision surgeries and other costs via the Stryker Broadspire claims program.
This is not the first time Broadspire Services has been engaged to handle claims stemming from a hip recall. Johnson & Johnson hired the company to perform similar work following the 2010 DePuy ASR hip implant recall. Bernstein Liebhard LLP is representing hundreds of people in ASR hip replacement lawsuits, and has gained a great deal of insight into Broadspire claims. Before you contact Broadspire, you may want to speak with a Stryker hip lawyer about your case.
Please keep in mind that anything you disclose during the Broadspire Stryker claims program could later be used as evidence during your Stryker hip recall lawsuit.
Mediation efforts in New Jersey have resulted in five Stryker lawsuit settlements over the now-recalled Rejuvenate and ABG II modular-neck … Read More >>
The federal judge overseeing hundreds of Stryker hip lawsuit filings in the U.S. District Court, District of Minnesota, has declined … Read More >>
The makers of a hip replacement now pending Stryker hip recall litigation have reported significant profit drops its first quarter … Read More >>